US2013304020A1PendingUtilityA1

Blood treatment systems and methods

Assignee: DEKA PRODUCTS LPPriority: Feb 27, 2007Filed: Apr 2, 2013Published: Nov 14, 2013
Est. expiryFeb 27, 2027(~0.6 yrs left)· nominal 20-yr term from priority
A61M 2205/3379A61M 2205/18A61M 2205/3324A61M 2205/3331A61M 2205/3317A61M 2205/3334A61M 2205/128A61M 1/1601A61M 2205/123A61M 2205/502G16H 20/40A61M 1/3462Y10T137/87893A61M 1/1696A61M 1/3652A61M 2205/12A61M 1/3609A61M 1/1613A61M 1/3646A61M 1/3441A61M 1/1635A61M 1/3465A61M 1/3427A61M 1/341A61M 1/1619A61M 2205/15A61M 5/172A61M 1/16A61M 1/365A61M 1/3622A61M 1/15A61M 1/362223A61M 1/1566A61M 1/362227G06F 11/30G16H 40/63G16H 40/60G06F 11/3089G06F 9/00A61M 1/15625A61M 1/362263A61M 1/362261A61M 1/1565A61M 1/1561A61M 1/362266A61M 1/362265A61M 1/3401A61M 1/36225A61M 1/155A61M 1/154A61M 1/3644A61M 1/267A61M 1/1694A61M 1/3626A61M 1/14A61M 1/1621A61M 1/3672
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Dialysis systems comprising actuators that cooperate to perform dialysis functions and sensors that cooperate to monitor dialysis functions are disclosed. According to one aspect, such a hemodialysis system comprises a user interface model layer, a therapy layer, below the user interface model layer, and a machine layer below the therapy layer. The user interface model layer is configured to manage the state of a graphical user interface and receive inputs from a graphical user interface. The therapy layer is configured to run state machines that generate therapy commands based at least in part on the inputs from the graphical user interface. The machine layer is configured to provide commands for the actuators based on the therapy commands.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 - 12 . (canceled) 
     
     
         13 . A method for controlling the administration of an anticoagulant in a dialysis system, the method comprising:
 storing, on at least one storage medium, an anticoagulant protocol comprising a maximum amount of anticoagulant;   automatically administering the anticoagulant according to the anticoagulant protocol; and   prohibiting the administration of additional anticoagulant after determining that the maximum amount of anticoagulant has been administered.   
     
     
         14 . The method of  claim 13 , wherein:
 the anticoagulant protocol comprises a prescribed rate of anticoagulant administration; and   automatically administering the anticoagulant according to the anticoagulant protocol comprises automatically administering the anticoagulant at the prescribed rate.   
     
     
         15 . The method of  claim 13 , wherein the anticoagulant protocol comprises a basal rate of anticoagulant administration and a maintenance rate of anticoagulant administration. 
     
     
         16 . The method of  claim 13 , wherein automatically administering the anticoagulant according to the anticoagulant protocol comprises automatically administering a bolus of anticoagulant via an arterial blood line prior to a dialysis operation. 
     
     
         17 . The method of  claim 13 , wherein automatically administering an anticoagulant according to the anticoagulant protocol comprises automatically administering a bolus of anticoagulant via a venous blood line prior to a dialysis operation. 
     
     
         18 . The method of  claim 17 , wherein automatically administering the bolus of anticoagulant via the venous blood line is performed in response to an indication that air is present in a blood flow path. 
     
     
         19 . At least one computer-readable medium encoded with instructions that, when executed on at least one processing unit, perform a method for controlling the administration of an anticoagulant in a dialysis system, the method comprising:
 electronically receiving an anticoagulant protocol comprising a maximum amount of anticoagulant;   controlling a plurality of actuators to administer the anticoagulant according to the anticoagulant protocol; and   prohibiting the administration of additional anticoagulant after determining that the maximum amount of anticoagulant has been administered.   
     
     
         20 - 34 . (canceled)

Join the waitlist — get patent alerts

Track US2013304020A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.